Core Viewpoint - The news highlights the recognition of Shengxiang Group with a nomination for the Jiangsu Provincial Quality Award, reflecting the city's commitment to quality improvement and innovation in driving high-quality development [1]. Group 1: Quality Recognition and Achievements - Shengxiang Group has been nominated for the Jiangsu Provincial Quality Award, contributing to a total of 10 provincial and national quality award nominations in the city [1]. - The city has implemented a "one-stop" service model, assisting 406 enterprises and resolving 465 quality issues this year [3]. Group 2: Support for Small and Micro Enterprises - A "quality management system certification enhancement action" has been launched, focusing on small and micro enterprises, leading to significant improvements in quality management practices [4]. - A case study from a Sino-German joint venture in pharmaceutical packaging illustrates how targeted interventions led to a reduction in defect rates from a new production line to 0.006%, significantly exceeding industry standards [5]. Group 3: Standards and Innovation - The city has made substantial progress in standardization, with 442 standards developed in the past five years, including 9 international standards, marking a shift from following to leading in various industries [6]. - The establishment of national and provincial standard committees in advanced materials and other sectors indicates the city's growing influence in standard-setting [7]. Group 4: Intellectual Property and Financial Support - From January to October, the city facilitated 199 instances of intellectual property pledge financing, amounting to 3.26 billion yuan, supporting innovation and development in enterprises [8]. - The market regulatory department is actively helping enterprises navigate overseas intellectual property challenges, enhancing their global competitiveness [8]. Group 5: Integrated Quality Management - The concept of "Big Quality" integrates various aspects of quality management, including standards, certification, and brand building, exemplified by Shengxiang Group's comprehensive quality management approach [9]. - The city is promoting a "chain-up" quality service model, addressing common quality issues across industries and facilitating financial support for small and micro enterprises [9][10].

Core Viewpoint - Yangtze River Pharmaceutical Group is committed to high-quality and sustainable development by aligning with world-class standards and implementing a comprehensive quality management system across all aspects of its operations [1][2][5]. Group 1: Quality Management Initiatives - The company emphasizes a "big quality" approach, focusing on product lifecycle quality, operational quality, digital application quality, and management quality to enhance overall quality coordination and upgrade [2]. - Yangtze River has established a robust drug quality risk management model, ensuring that all products meet standard requirements through a data-driven, rapid-response safety system [2][4]. - The company has achieved over 180 generic drug varieties that have passed or are deemed equivalent in quality and efficacy evaluations, reinforcing the quality equivalence with original drugs [2]. Group 2: Operational Quality and Culture - Yangtze River promotes a culture of quality through leadership, strategy, personnel, and resource collaboration, establishing clear quality responsibilities and fostering a continuous improvement atmosphere [3]. - The company has implemented over 1,000 quality improvement projects, generating over 500 million yuan in economic benefits and winning 31 international quality management awards [3]. - The annual "Quality Month" activities help instill quality culture among employees, enhancing their sense of ownership and commitment to quality [3]. Group 3: Smart Manufacturing and Digital Transformation - The company leverages digital technologies to enhance production and management processes, achieving data sharing and dynamic analysis for quality decision-making [4]. - Yangtze River's subsidiary, Longfeng Hall, has become the first in Jiangsu Province to pass the national high-tech standardization pilot for intelligent manufacturing in traditional Chinese medicine [4]. - The company aims to be recognized as a top-tier intelligent factory by 2024, reflecting its commitment to improving quality control precision and management efficiency through digital upgrades [4]. Group 4: Sustainable Development and Green Manufacturing - Yangtze River prioritizes green development as a prerequisite for high-quality growth, implementing green manufacturing technologies and practices throughout its operations [12]. - The company has converted wastewater from traditional Chinese medicine production into biogas, generating significant revenue and reducing carbon emissions [11]. - Eight of its factories have been recognized as national green factories, demonstrating the company's commitment to environmental sustainability [12]. Group 5: International Standards and Recognition - Yangtze River has been pursuing the EFQM Global Award since 2012, achieving a five-star rating in 2021 and recently receiving a seven-star certification, which positions the company to compete for the seven-diamond EFQM Global Award [9][10]. - The EFQM model has been integrated into the company's operations, driving improvements across various departments and enhancing overall management capabilities [15]. - The company actively engages in cross-cultural communication training to support its internationalization efforts and ensure compliance with global quality standards [16].

Core Insights - Yangtze River Pharmaceutical Group has achieved the EFQM "Seven Stars Certification," marking a significant milestone in its development journey, just 50 months after receiving the EFQM Global Award "Five Stars" [1][5] - The certification reflects the company's strong capabilities in enterprise management and its commitment to high-quality development [1][5] Group 1: Achievements and Recognition - The EFQM Global Award is one of the three major quality awards globally, serving as a benchmark for companies to assess their management maturity [5] - Since obtaining the "Five Stars" honor in 2021, the company has continued to pursue excellence through initiatives focused on quality enhancement and internal capabilities [5][6] - The company has launched several initiatives, including "Learning Year," "Digital Intelligence Year," "Compliance Year," and "Health Year," to strengthen various management systems [5][6] Group 2: Evaluation Process - The on-site evaluation for the "Seven Stars Certification" took place from April 14 to 18, involving five global experts from Germany, the UK, Portugal, Spain, and China [5][6] - The evaluation covered multiple dimensions, including strategic execution, cultural implementation, innovation mechanisms, and operational performance, with 30 interview sessions and over 450 questions asked [5][6] Group 3: Future Plans - Following the certification, the company aims to enhance its capabilities further and is set to pursue the "Six Diamonds" EFQM Global Award in 2024 [5][6] - The company plans to leverage this achievement as a new starting point for comprehensive improvement and to deepen the application of the EFQM model [6] - The company is committed to building a "Harmonious" ecosystem and learning from global best practices to advance towards becoming a world-class pharmaceutical and health industry group [6]